(Q64836258)
Statements
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE) (English)
0 references
24 November 2017
0 references
September 2019
0 references
32
0 references
18 year
0 references